These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20373002)

  • 1. Decreased myocardial expression of dystrophin and titin mRNA and protein in dilated cardiomyopathy: possibly an adverse effect of TNF-alpha.
    Ahmad S; Rai TS; Khullar M; Bahl A; Saikia UN; Thungapathra M; Kumar RM; Mahajan R; Talwar KK
    J Clin Immunol; 2010 Jul; 30(4):520-30. PubMed ID: 20373002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts.
    Makarenko I; Opitz CA; Leake MC; Neagoe C; Kulke M; Gwathmey JK; del Monte F; Hajjar RJ; Linke WA
    Circ Res; 2004 Oct; 95(7):708-16. PubMed ID: 15345656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy.
    Satoh M; Nakamura M; Tamura G; Makita S; Segawa I; Tashiro A; Satodate R; Hiramori K
    J Am Coll Cardiol; 1997 Mar; 29(4):716-24. PubMed ID: 9091515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart.
    Torre-Amione G; Kapadia S; Lee J; Durand JB; Bies RD; Young JB; Mann DL
    Circulation; 1996 Feb; 93(4):704-11. PubMed ID: 8640999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy.
    Nagueh SF; Shah G; Wu Y; Torre-Amione G; King NM; Lahmers S; Witt CC; Becker K; Labeit S; Granzier HL
    Circulation; 2004 Jul; 110(2):155-62. PubMed ID: 15238456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha B-crystallin mutation in dilated cardiomyopathy.
    Inagaki N; Hayashi T; Arimura T; Koga Y; Takahashi M; Shibata H; Teraoka K; Chikamori T; Yamashina A; Kimura A
    Biochem Biophys Res Commun; 2006 Apr; 342(2):379-86. PubMed ID: 16483541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel frameshift mutation in the giant muscle filament titin in a large Australian family with dilated cardiomyopathy.
    Gerull B; Atherton J; Geupel A; Sasse-Klaassen S; Heuser A; Frenneaux M; McNabb M; Granzier H; Labeit S; Thierfelder L
    J Mol Med (Berl); 2006 Jun; 84(6):478-83. PubMed ID: 16733766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy.
    Gerull B; Gramlich M; Atherton J; McNabb M; Trombitás K; Sasse-Klaassen S; Seidman JG; Seidman C; Granzier H; Labeit S; Frenneaux M; Thierfelder L
    Nat Genet; 2002 Feb; 30(2):201-4. PubMed ID: 11788824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated bout effect on the cytoskeletal proteins titin, desmin, and dystrophin in rat skeletal muscle.
    Lehti TM; Kalliokoski R; Komulainen J
    J Muscle Res Cell Motil; 2007; 28(1):39-47. PubMed ID: 17436058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of titin and contractile proteins in failing human myocardium.
    Hein S; Scholz D; Fujitani N; Rennollet H; Brand T; Friedl A; Schaper J
    J Mol Cell Cardiol; 1994 Oct; 26(10):1291-306. PubMed ID: 7869390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of titin/connectin N2-B mutations found in cardiomyopathy.
    Matsumoto Y; Hayashi T; Inagaki N; Takahashi M; Hiroi S; Nakamura T; Arimura T; Nakamura K; Ashizawa N; Yasunami M; Ohe T; Yano K; Kimura A
    J Muscle Res Cell Motil; 2005; 26(6-8):367-74. PubMed ID: 16465475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Titin mutations as the molecular basis for dilated cardiomyopathy.
    Itoh-Satoh M; Hayashi T; Nishi H; Koga Y; Arimura T; Koyanagi T; Takahashi M; Hohda S; Ueda K; Nouchi T; Hiroe M; Marumo F; Imaizumi T; Yasunami M; Kimura A
    Biochem Biophys Res Commun; 2002 Feb; 291(2):385-93. PubMed ID: 11846417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of gypenosides on cardiac function and expression of cytoskeletal genes of myocardium in diabetic cardiomyopathy rats.
    Ge M; Ma S; Tao L; Guan S
    Am J Chin Med; 2009; 37(6):1059-68. PubMed ID: 19938216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress-induced dilated cardiomyopathy in a knock-in mouse model mimicking human titin-based disease.
    Gramlich M; Michely B; Krohne C; Heuser A; Erdmann B; Klaassen S; Hudson B; Magarin M; Kirchner F; Todiras M; Granzier H; Labeit S; Thierfelder L; Gerull B
    J Mol Cell Cardiol; 2009 Sep; 47(3):352-8. PubMed ID: 19406126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcomeric protein mutations in dilated cardiomyopathy.
    Chang AN; Potter JD
    Heart Fail Rev; 2005 Sep; 10(3):225-35. PubMed ID: 16416045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different electrophoretic techniques produce conflicting data in the analysis of myocardial samples from dilated cardiomyopathy patients: protein levels do not necessarily reflect mRNA levels.
    dos Remedios CG; Berry DA; Carter LK; Coumans JV; Heinke MY; Kiessling PC; Seeto RK; Thorvaldson T; Trahair T; Yeoh T; Yao M; Gunning PW; Hardeman E; Humphery-Smith I; Naidoo D; Keogh A
    Electrophoresis; 1996 Jan; 17(1):235-8. PubMed ID: 8907547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha-converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy.
    Satoh M; Nakamura M; Saitoh H; Satoh H; Maesawa C; Segawa I; Tashiro A; Hiramori K
    Circulation; 1999 Jun; 99(25):3260-5. PubMed ID: 10385500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy.
    Schoenauer R; Emmert MY; Felley A; Ehler E; Brokopp C; Weber B; Nemir M; Faggian GG; Pedrazzini T; Falk V; Hoerstrup SP; Agarkova I
    Basic Res Cardiol; 2011 Mar; 106(2):233-47. PubMed ID: 21069531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-linked dilated cardiomyopathy. Novel mutation of the dystrophin gene.
    Franz WM; Cremer M; Herrmann R; Grünig E; Fogel W; Scheffold T; Goebel HH; Kircheisen R; Kübler W; Voit T
    Ann N Y Acad Sci; 1995 Mar; 752():470-91. PubMed ID: 7755293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.
    Beqqali A; Bollen IA; Rasmussen TB; van den Hoogenhof MM; van Deutekom HW; Schafer S; Haas J; Meder B; Sørensen KE; van Oort RJ; Mogensen J; Hubner N; Creemers EE; van der Velden J; Pinto YM
    Cardiovasc Res; 2016 Oct; 112(1):452-63. PubMed ID: 27496873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.